Redox imbalance and lung fibrosis

Antioxidants and Redox Signaling

Volumn 10, Issue 2, 2008, Pages 249-252

  Kinnula, Vuokko L ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

APOPTOSIS; DISEASE MODEL; DRUG EFFECT; EDITORIAL; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION;

EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMANS; OXIDATION-REDUCTION; PULMONARY FIBROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 37549013287     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1912     Document Type: Editorial

References (39)

1. American Thoracic Society and European Respiratory Society. American Thoracic Society/European Respiratory Society: international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am.J Respir Crit Care Med 165: 277-304, 2002.
2. Baran CP, Opalek JM, McMaken S, Newland CA, O'brien JM Jr, Hunter MG, Bringardner BD, Monick MM, Brigstock DR, Stromberg PC, Hunninghake GW, and Marsh CB. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 176: 78-89, 2007.
3. Behr J, Degenkolb B, Maier K, Braun B, Beinert T, Krombach F, Vogelmeier C, and Fruhmann G. Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur Respir J 8: 1286-1292, 1995.
4. Bringardner BD, Baran CP, Eubank TD, and Marsh CB. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 10: 287-301, 2008.
5. 2, PPARγ agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages. Antioxid Redox Signal 10: 253-260, 2008.
6. Cantin AM, Hubbard RC, and Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139: 370-372, 1989.
7. Carraway MS, Suliman HB, Kliment C, Welty-Wolf KE, Oury TD, and Piantadosi CA. Mitochondrial biogenesis in the pulmonary vasculature during inhalational lung injury and fibrosis. Antioxid Redox Signal 10: 269-275, 2008.
8. Cho HY, Reddy SP, Yamamoto M, and Kleeberger SR. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 18: 1258-1260, 2004.
9. Day BJ. Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 10: 355-370, 2008.
10. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De VP, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, and Montanari M. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353: 2229-2242, 2005.
11. Fattman CL. Apoptosis in pulmonary fibrosis: too much or not enough? Antioxid Redox Signal 10: 379-385, 2008.
12. Fattman CL, Chang LY, Termin TA, Petersen L, Enghild JJ, and Oury TD. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med 35: 763-771, 2003.
13. Flaherty KR, Toews GB, Travis WD, Colby TV, Kazerooni EA, Gross BH, Jain A, Strawderman RL III, Paine R, Flint A, Lynch JP III, and Martinez FJ. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19: 275-283, 2002.
14. Gao F, Kinnula VL, Myllärniemi M, and Oury TD. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal 10: 343-354, 2008.
15. Gauldie J. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165: 1205-1206, 2002.
16. Ghio AJ, Stonehuerner J, Richards J, and Devlin RB. Iron homeostasis in the lung following asbestos exposure. Antioxid Redox Signal 10: 371-377, 2008.
17. Kamp DW, Graceffa P, Pryor WA, and Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 12: 293-315, 1992.
18. Keski-Oja J, Koli K, and von MH. TGF-beta activation by traction? Trends Cell Biol 14: 657-659, 2004.
19. Kinnula VL, Fattman CL, Tan RJ, and Oury TD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 172: 417-422, 2005.
20. Kinnula VL, Hodgson UA, Lakari EK, Tan RJ, Sormunen RT, Soini YM, Kakko SJ, Laitinen TH, Oury TD, and Paakko PK. Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology 49: 66-74, 2006.
21. Kinnula VL, Vuorinen K, Ilumets H, Rytila P, and Myllarniemi M. Thiol proteins, redox modulation and parenchymal lung disease. Curr Med Chem 14: 213-222, 2007.
22. Kliment CR, Tobolewski JM, Manni ML, Tan RJ, Enghild J, and Oury TD. Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung. Antioxid Redox Signal 10: 261-268, 2008.
23. Koli K, Myllärniemi M, Keski-Oja J, and Kinnula VL. Transforming growth factor-β activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 10: 333-342, 2008.
24. Liu R-M. Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal 10: 303-319, 2008.
25. Lyons RM, Keski-Oja J, and Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 106: 1659-1665, 1988.
26. Manning CB, Vallyathan V, and Mossman BT. Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2: 191-200, 2002.
27. Montuschi P, Ciabattoni G, Paredi P, Pantelidis P, du Bois RM, Kharitonov SA and Barnes PJ. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 158: 1524-1527, 1998.
28. Nelson KK and Melendez JA. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37: 768-784, 2004.
29. O'Neill HC, Rancourt RC, and White CW. Lipoic acid suppression of neutrophil respiratory burst: effect of NADPH. Antioxid Redox Signal 10: 277-285, 2008.
30. Peltoniemi M, Kaarteenaho-Wiik R, Saily M, Sormunen R, Paakko P, Holmgren A, Soini Y, and Kinnula VL. Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Hum Pathol 35: 1000-1007, 2004.
31. Rahman I, Yang SR, and Biswas SK. Current concepts of redox signaling in the lungs. Antioxid Redox Signal 8: 681-689, 2006.
32. Saleh D, Barnes PJ, and Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155: 1763-1769, 1997.
33. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, and Mossman BT. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 34: 1117-1129, 2003.
34. Strieter RM. Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165: 1206-1207, 2002.
35. Taipale J, Koli K, and Keski-Oja J. Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 267: 25378-25384, 1992.
36. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem 270: 30334-30338, 1995.
37. Tiitto L, Kaarteenaho-Wiik R, Sormunen R, Holmgren A, Paakko P, Soini Y, and Kinnula VL. Expression of the thioredoxin system in interstitial lung disease. J Pathol 201: 363-370, 2003.
38. Tiitto LH, Peltoniemi MJ, Kaarteenaho-Wiik RL, Soini YM, Paakko PK, Sormunen RT, and Kinnula VL. Cell-specific regulation of gamma-glutamylcysteine synthetase in human interstitial lung diseases. Hum Pathol 35: 832-839, 2004.
39. Walters DM, Cho H-Y, and Kleeberger SR. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Antioxid Redox Signal 10: 321-332, 2008.